chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: Reported Symptoms: 10067482:NO ADVERSE EVENT; Narrative: Patient contacted regarding recent COVID-19 immunization on 11/10/21. Patient erroneously received a full dose of Moderna vaccine instead of a half dose booster per CDC guidelines. Patient was provided this information and informed that we would not expect any significant consequences as a result of this error. Patient was asked about any potential adverse events and none were reported and patient stated he was feeling fine since he received the vaccine. The patient was appreciative of the phone call and agreed to contact the pharmacy or his provider with any additional questions or adverse events. PCP to be flagged to this note for awareness as well. Other Relevant HX: Other: none
Sex: M
Vaccine: FLUX
Symptoms: Muscle spasms, Nausea, Pyrexia, Vomiting
Clinical narrative: Reported Symptoms: 10011285:CRAMP; 10016558:FEVER; 10028813:NAUSEA; 10047700:VOMITING;  Narrative:  Other Relevant HX:  Other NAUSEA AND VOMITING: CRAMP: FEVER
Sex: M
Vaccine: COVID19
Symptoms: Hypertension, Malaise
Clinical narrative: Reported Symptoms: 10020772:HYPERTENSION; 10025482:MALAISE; Narrative: Other Relevant HX:  Other: MALAISE; HYPERTENSION
Sex: M
Vaccine: FLUX
Symptoms: Cough, Dyspnoea, Sneezing
Clinical narrative: Reported Symptoms: 10011232:COUGHING; 10013963:DYSPNEA; 10041232:SNEEZING; Narrative: Other Relevant HX: Other: COUGH, SNEEZING, DYSPNEA
Age: 65.0
Sex: M
Vaccine: PPV
Symptoms: Rash, Rash papular
Clinical narrative: Reported Symptoms: 10033730:PAPULAR SKIN ERUPTION; 10037844:RASH; Narrative:  Other Relevant HX: Other: RASH; PAPULAR ERUPTION
Sex: F
Vaccine: FLUX
Symptoms: Scar, Skin burning sensation
Clinical narrative: Reported Symptoms: 10006791:BURNING SENSATION SKIN;  Narrative: Other Relevant HX: Other: burning sensation on scar
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Reported Symptoms: 10003299:ARTHRALGIA; 10019211:HEADACHE; 10023222:JOINT PAIN; Narrative: Other Relevant HX: Other: HEADACHE; JOINT PAIN
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Headache
Clinical narrative: Reported Symptoms: 10003239:ARTHRALGIA; 10019211:HEADACHE; 10023222:JOINT PAIN; Narrative: Other Relevant HX: Other: HEADACHE; JOINT PAIN
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Rash
Clinical narrative: Reported Symptoms: 10037844:RASH; Narrative: Patient with L arm pain with the first dose. He had a rash on his back after the second dose. Both were moderna. Other Relevant HX: Patient received outside of the facility. He had left arm pain for 3 days after the first dose, and a back rash after the second dose- pt advised to not receive moderna again. Other: RASH
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Computerised tomogram head normal, Headache, Myalgia, Night sweats
Clinical narrative: Reported Symptoms: 10003239:ARTHRALGIA; 10019211:HEADACHE; 10028411:MYALGIA; 10029410:NIGHT SWEATS;  Narrative: Patient has had migratory and severe myalgias and arthralgias starting withi8n 24-36 hours of getting his firt covid moderna immunization on 4 August 2021. He is still having symptoms. Had severe temporal artery tenderness and headaches. ESR Mildly elevated. CT of head negative. Symptoms temorarily improve with Tylenol and/or Naproxen. Other Relevant HX: Has had continuous symptoms since his immunization on 8/4/2021 Other: profuse night sweats
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Red blood cell sedimentation rate increased, Tenderness
Clinical narrative: Reported Symptoms: 10003239:ARTHRALGIA; 10019211:HEADACHE; 10028411:MYALGIA; 10029410:NIGHT SWEATS;  Narrative: Patient has had migratory and severe myalgias and arthralgias starting withi8n 24-36 hours of getting his firt covid moderna immunization on 4 August 2021. He is still having symptoms. Had severe temporal artery tenderness and headaches. ESR Mildly elevated. CT of head negative. Symptoms temorarily improve with Tylenol and/or Naproxen. Other Relevant HX: Has had continuous symptoms since his immunization on 8/4/2021 Other: profuse night sweats
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Reported Symptoms: 10013963:DYSPNEA; Narrative: Patient is a 69 year old male who received his first Moderna COVID-19 vaccination on 2/23/2021. On 6/21/2021 he reported worsening dyspnea related to the COVID-19 vaccination, which he was prescribed Tiotropium. Other Relevant HX: Chronic low back pain, HTN, Urethral stricture, Chronic venous insufficiency, ED, H/A, h/o DVT, male hypogonadism, knee pain, hyperlipidemia, neurogenic bladder, Fe deficiency, GERD, abnormal endoscopy, chronic peptic ulter of duodenum, impaired fasting glycemia, heterozygous factor V Leiden mutation, h/o recurrent UTIs Other: DYSPNEA
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema
Clinical narrative: Reported Symptoms: 10082424:ANGIOEDEMA; Narrative: Other Relevant HX: Other: ANGIOEDEMA
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Reported Symtoms: 10037844:RASH;   Narrative: Other Relevant HX:
Age: 29.0
Sex: M
Vaccine: PPV
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037944:RASH;  Narrative: It was a historical reaction occurring outside of the VA.  Other Relevant HX:  Other: RASH
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037944:RASH; Narrative: Other Relevant HX: Other: RASH
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Cellulitis, Psoriasis, Rash, Urticaria
Clinical narrative: Reported Symptoms: 10007882:CELLULITIS; 10037844:RASH; 10046735:URTICARIA; Narrative: The allergy to COVID-19 Vaccine was removed on 7/23/21. This reaction was either an erroneous entry or was found to no longer be a true allergy. COVID Vaccine reaction was a flare of psoriasis. Not a contraindication to receiving vaccine in the future. Other Relevant HX: Other: URTICARIA; CELLULITIS
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Reported Symptoms: 10037087:PRURITUS; 10046735:URTICARIA; Narrative: Other Relevant HX: none Other: URTICARIA
Sex: M
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Reported Symptoms: 10046735:URTICARIA; Narrative: Other Relevant HX: Other: URTICARIA
Sex: M
Vaccine: COVID19
Symptoms: Dyspepsia, Hyperglycaemia, Rash
Clinical narrative: Reported Symptoms: 10019326:HEARTBURN; 10020639:HYPERGLYCEMIA; 10037844:RASH;  Narrative: Other Relevant HX;  Other:  RASH; HEARTBURN: HYPERGLYCEMIA
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Arthralgia, Joint swelling, Memory impairment
Clinical narrative: Reported Symptoms: 10001768:ALOPECIA; 10027174:MEMORY IMPAIRED; 10042722:SWOLLEN JOINTS;  Narrative: 11/2/23: Patient reports ADR to COVID-19 vaccine to provider, stating joint pain since receiving vaccine. Patient has been followed by rheumatology and trialed several medications over the past 1.5 years, and is now taling meloxican. Provider notes there is no official diagnosis.  Other Relevant HX: JOINT SWELLING; ALOPECIA; MEMORY IMPAIRMENT
Sex: M
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Reported Symptoms: 10046735:URTICARIA;  Narrative:  Other Relevant HX: Other: URTICARIA
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Feeling cold, Headache, Nausea, Pain
Clinical narrative: Reported Symptoms: 10046735:URTICARIA;  Narrative: patient experienced fever, chills, headache, nausea and body aches after getting the covid shot. She then developed hives on her body. They were red, pink, and itchy. Patient took benadryl liquid.  Other Relevant HX: Other: URTICARIA
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Urticaria
Clinical narrative: Reported Symptoms: 10046735:URTICARIA;  Narrative: patient experienced fever, chills, headache, nausea and body aches after getting the covid shot. She then developed hives on her body. They were red, pink, and itchy. Patient took benadryl liquid.  Other Relevant HX: Other: URTICARIA
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia
Clinical narrative: Reported Symptoms: 10047862:WEAKNESS; 10047865:WEAKNESS GENERALIZED; Narrative: Patient experienced weakness which is a common side effect of the covid-19 vaccines. He recieved the vaccine outside of the clinic. Other Relevant HX: Appears patient had received vaccine outside of clinic, was reported by PCP. Other: WEAKNESS
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Injection site erythema, Injection site induration, Injection site swelling, Pain
Clinical narrative: Relevant Symptoms: 10012727:DIARRHEA; 10037844:RASH; 1004269: SWELLIN ARM: Narrative: PMH of anxiety, morbid obesity, insomnia. Administered first dose of Moderna COVID-19 vaccine on 03/16/2021 (Lot# 038A21A; left arm) at the clinic. No reported adversae effects. Received second dose of series on 4/13/2021. Contacted clinic call center on 4/14/2021 stating that she had swelling and pain (8 out of 10) of the right arm and had as well as rash to arm and neck. Stated she had redness and swlling of the injection sire. Denied fever (96.7F reported), facial/tongue/lip swelling, abdominal pain/swelling or SOB. Endorsed episode of diarrhea the day prior, but resolved. Follow-up same day walk in to clinic to evaluate reaction, RN noted patient's vaccine site was slightly warm, semi-firm injection site, no discoloration/redness to area. Skin warm and dry, radial pulses present. Provider recommended ice pack and acetaminophen for pain, but unclear if patient followed up with treatment. Other Relevant HX:  Other: RASH; SWELLING OF ARM
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Rash, Vaccination site warmth
Clinical narrative: Relevant Symptoms: 10012727:DIARRHEA; 10037844:RASH; 1004269: SWELLIN ARM: Narrative: PMH of anxiety, morbid obesity, insomnia. Administered first dose of Moderna COVID-19 vaccine on 03/16/2021 (Lot# 038A21A; left arm) at the clinic. No reported adversae effects. Received second dose of series on 4/13/2021. Contacted clinic call center on 4/14/2021 stating that she had swelling and pain (8 out of 10) of the right arm and had as well as rash to arm and neck. Stated she had redness and swlling of the injection sire. Denied fever (96.7F reported), facial/tongue/lip swelling, abdominal pain/swelling or SOB. Endorsed episode of diarrhea the day prior, but resolved. Follow-up same day walk in to clinic to evaluate reaction, RN noted patient's vaccine site was slightly warm, semi-firm injection site, no discoloration/redness to area. Skin warm and dry, radial pulses present. Provider recommended ice pack and acetaminophen for pain, but unclear if patient followed up with treatment. Other Relevant HX:  Other: RASH; SWELLING OF ARM
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Illness, Suspected product contamination
Clinical narrative: CONTAMINATED; SICK; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Batch number was not provided and have been requested. No concomitant medications were reported. On an unspecified date, the patient experienced contaminated, and sick (dose series 1). Patient was talking to someone and was explaining to the lady what happened and she didn't want to talk to me. Patient took covid 19 shot and it was contaminated, it messed patient's life up and was sick, medicine was high which patient can't (SCN). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the contaminated and sick was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000317081.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Cardiac disorder, Chest discomfort, Haemoptysis, Liver disorder, Mouth haemorrhage
Clinical narrative: CONTAMINATED; SICK; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Batch number was not provided and have been requested. No concomitant medications were reported. On an unspecified date, the patient experienced contaminated, and sick (dose series 1). Patient was talking to someone and was explaining to the lady what happened and she didn't want to talk to me. Patient took covid 19 shot and it was contaminated, it messed patient's life up and was sick, medicine was high which patient can't (SCN). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the contaminated and sick was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000317081.
Sex: U
Vaccine: COVID19, COVID19
Symptoms: Poor quality product administered, Product storage error, Renal disorder, Suspected product contamination, Thrombosis
Clinical narrative: CONTAMINATED; SICK; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (dose series 1) (suspension for injection, intramuscular, batch number was not reported) dose, start therapy date were not reported for covid-19 prophylaxis. Batch number was not provided and have been requested. No concomitant medications were reported. On an unspecified date, the patient experienced contaminated, and sick (dose series 1). Patient was talking to someone and was explaining to the lady what happened and she didn't want to talk to me. Patient took covid 19 shot and it was contaminated, it messed patient's life up and was sick, medicine was high which patient can't (SCN). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the contaminated and sick was not reported. This report was non-serious. This report was associated with a product quality complaint: 90000317081.
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder
Clinical narrative: she is having a heart procedure; This is a spontaneous report received from a Consumer or other non HCP from medical information team, Program ID.  A 70-year-old female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Nov2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pfizer covid vaccine (DOSE NUMBER UNKNOWN), for Covid-19 Immunization. The following information was reported: CARDIAC DISORDER (medically significant), outcome "unknown", described as "she is having a heart procedure". Therapeutic measures were taken as a result of cardiac disorder. The patient stated that she was having a heart procedure and her doctor had no idea where it came from and he thought she had it for a long time. She stated that she read something that said that there could be heart problems with the COVID-19 vaccine. She previously received a Pfizer Covid-19 vaccine about Nov (2023), and added that she had been receiving the Pfizer Covid vaccines since it was first given about two years ago (unknown date).   The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.
Sex: F
Vaccine: HEP
Symptoms: Expired product administered
Clinical narrative: Engerix-B was administered to the patient and he realized after, that it was expired; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a adult female patient who received HBV (Engerix B) (batch number 9255P, expiry date 15-FEB-2024) for prophylaxis.   On 10-MAR-2024, the patient received the 2nd dose of Engerix B. On 10-MAR-2024, an unknown time after receiving Engerix B, the patient experienced expired vaccine used (Verbatim: Engerix-B was administered to the patient and he realized after, that it was expired). The outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 22-MAR-2024 The pharmacist stated that he realized after the Engerix-B was administered to the patient, that it was expired which led to expired vaccine used. The reporter consented to follow up via postal code.
Age: 27.0
Sex: F
Vaccine: HEP
Symptoms: Abdominal distension, Amenorrhoea, Dizziness, Fluid retention, Joint swelling
Clinical narrative: Donor received Hepatitis B vaccine on 03/14/24 and returned to the center on 03/26/24 reporting that after the vaccination, she had ammenorrhea, mood swings, swelling in her abdomen and hips, fluid retention, nausea, and dizziness. Donor denies intercourse within the past year and contributes all symptoms to receiving the vaccine. Donor had symptoms of dizziness and nausea for two days which subsided without medical intervention. Donor continues to have symptoms of fluid retention, swelling in abdomen and hips, mood swings, and ammenorrhea.  Donor states has not spoken to PCP regarding these symptoms.
Age: 27.0
Sex: F
Vaccine: HEP
Symptoms: Mood swings, Nausea
Clinical narrative: Donor received Hepatitis B vaccine on 03/14/24 and returned to the center on 03/26/24 reporting that after the vaccination, she had ammenorrhea, mood swings, swelling in her abdomen and hips, fluid retention, nausea, and dizziness. Donor denies intercourse within the past year and contributes all symptoms to receiving the vaccine. Donor had symptoms of dizziness and nausea for two days which subsided without medical intervention. Donor continues to have symptoms of fluid retention, swelling in abdomen and hips, mood swings, and ammenorrhea.  Donor states has not spoken to PCP regarding these symptoms.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Injection site induration, Injection site reaction, Injection site warmth
Clinical narrative: Hardness and warmth at injection site. Mottling of skin  on upper arm.  Exhaustion, aching muscles, fever and shivering.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Livedo reticularis, Myalgia, Pyrexia
Clinical narrative: Hardness and warmth at injection site. Mottling of skin  on upper arm.  Exhaustion, aching muscles, fever and shivering.
Age: 3.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Best use date of 3/21/2024. Administered 3/22/24.
Age: 60.0
Sex: M
Vaccine: TDAP
Symptoms: Myalgia, Rash
Clinical narrative: Rash to right arm and pain in biceps
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Asthenia, Bladder catheterisation, COVID-19, Culture urine positive, Decreased appetite
Clinical narrative: Admit date: 3/18/2024  Discharge date: 03/22/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP   Reason for Admission: failure to thrive   Hospital Course: 80 YO female with h/o pelvis fracture compliacted by bladder rupture and vesicular cutaneous fistula s/p bilateral nephrostomy tubes, DVT on xarelto presented with poor appetite and fatigue. Found to have leukocytosis with concern for potential infection in urinary system.  Pt was placed on IV zosyn. Xarelto was held. Urology consulted, Foley was inserted, remain until closure of fistula. Had IR nephrostomy tube exchange on 3/21. Did well after the procedure. Xarelto resumed. Will transition to oral cipro x 3 days for total of 6-day treatment. Pt is discharged to home under stable condition.   Recurrent vesicular-cutaneous fistula  History of bladder rupture s/p bilateral nephrostomy tubes (5/2023) - UA positive, urine culture growing Pseudomonas. - Urology consulted, Foley placed, remain until closure of fistula. IR nephrostomy tube exchange done on 3/22.  - Treated with Zosyn (3/18-). Transition to oral cipro x another 3 days - F/u with outpatient urology   Generalized weakness Poor appetite -may be secondary to recent COVID-19 infection, tested positive 3/10 -encourage oral intake and continue IVF - RD consulted. Ensure added  Stage 4 sacral wound -no drainage, does not appear infected  -follows wound outpatient, wound care consulted   Hx of DVT  - resumed home xarelto  Issues Requiring Follow Up: (Who, what, when, and how communicated?)  Urology  Discharged to Home Health Care Services
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: Decubitus ulcer, Fatigue, Leukocytosis, Nephrostomy, Pseudomonas infection
Clinical narrative: Admit date: 3/18/2024  Discharge date: 03/22/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP   Reason for Admission: failure to thrive   Hospital Course: 80 YO female with h/o pelvis fracture compliacted by bladder rupture and vesicular cutaneous fistula s/p bilateral nephrostomy tubes, DVT on xarelto presented with poor appetite and fatigue. Found to have leukocytosis with concern for potential infection in urinary system.  Pt was placed on IV zosyn. Xarelto was held. Urology consulted, Foley was inserted, remain until closure of fistula. Had IR nephrostomy tube exchange on 3/21. Did well after the procedure. Xarelto resumed. Will transition to oral cipro x 3 days for total of 6-day treatment. Pt is discharged to home under stable condition.   Recurrent vesicular-cutaneous fistula  History of bladder rupture s/p bilateral nephrostomy tubes (5/2023) - UA positive, urine culture growing Pseudomonas. - Urology consulted, Foley placed, remain until closure of fistula. IR nephrostomy tube exchange done on 3/22.  - Treated with Zosyn (3/18-). Transition to oral cipro x another 3 days - F/u with outpatient urology   Generalized weakness Poor appetite -may be secondary to recent COVID-19 infection, tested positive 3/10 -encourage oral intake and continue IVF - RD consulted. Ensure added  Stage 4 sacral wound -no drainage, does not appear infected  -follows wound outpatient, wound care consulted   Hx of DVT  - resumed home xarelto  Issues Requiring Follow Up: (Who, what, when, and how communicated?)  Urology  Discharged to Home Health Care Services
Age: 79.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Vesicourethral fistula
Clinical narrative: Admit date: 3/18/2024  Discharge date: 03/22/2024  Admitting Physician: DO   Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP   Reason for Admission: failure to thrive   Hospital Course: 80 YO female with h/o pelvis fracture compliacted by bladder rupture and vesicular cutaneous fistula s/p bilateral nephrostomy tubes, DVT on xarelto presented with poor appetite and fatigue. Found to have leukocytosis with concern for potential infection in urinary system.  Pt was placed on IV zosyn. Xarelto was held. Urology consulted, Foley was inserted, remain until closure of fistula. Had IR nephrostomy tube exchange on 3/21. Did well after the procedure. Xarelto resumed. Will transition to oral cipro x 3 days for total of 6-day treatment. Pt is discharged to home under stable condition.   Recurrent vesicular-cutaneous fistula  History of bladder rupture s/p bilateral nephrostomy tubes (5/2023) - UA positive, urine culture growing Pseudomonas. - Urology consulted, Foley placed, remain until closure of fistula. IR nephrostomy tube exchange done on 3/22.  - Treated with Zosyn (3/18-). Transition to oral cipro x another 3 days - F/u with outpatient urology   Generalized weakness Poor appetite -may be secondary to recent COVID-19 infection, tested positive 3/10 -encourage oral intake and continue IVF - RD consulted. Ensure added  Stage 4 sacral wound -no drainage, does not appear infected  -follows wound outpatient, wound care consulted   Hx of DVT  - resumed home xarelto  Issues Requiring Follow Up: (Who, what, when, and how communicated?)  Urology  Discharged to Home Health Care Services
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Blood creatinine increased, COVID-19 pneumonia, Hypervolaemia
Clinical narrative: Admit date: 3/20/2024  Discharge date: 3/26/2024 (AMA)  Admitting Physician: MD   Attending Physician at the Time of Discharge: Dr. Primary Care Physician: DO Reason for Admission: Covid pnuemonitis / Volume overload  Brief Summary of Hospital Stay:   Pt was admitted for AKI, AHRF 2/2 covid and volume overload who underwent diuresis with worsening of renal disease, but improvement of oxygenation.  Patient Cr at time she left AMA was increasing, discussed with patient who stated she adamant about leaving. Explained risks of leaving and benefits of staying including if she leaves she could die. Patient was Aox3, able to exhibit capacity with decision, Father updated over phone. Pt still decided to leave AMA. Discharge plan otherwise including diuretics and need for bicarb discussed before patient left. Left AMA.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Muscular weakness, Transient ischaemic attack
Clinical narrative: Admit date: 3/25/2024  Discharge date: 3/27/2024  Admitting Physician: MD   Attending Physician at the Time of Discharge: MD  Primary Care Physician: MD Reason for Admission: R/O Stroke  Brief Summary of Hospital Stay:  Pt presented for RUE weakness / AKI which resolved in <24h.  She was believed to have UTI but this was later not believed.  She did get dose of abx.  She was observed overnight and continued to be symptom free. Renal function improved. She was discharged to f./u as outpatient for suspected TIA with GDMT. Discharged to Home
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Angiotensin converting enzyme, Antineutrophil cytoplasmic antibody, Antinuclear antibody, Anxiety, Blood thyroid stimulating hormone
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Borrelia test, Chest X-ray, Chills, DNA antibody, Differential white blood cell count
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Fatigue, Fear, Full blood count, Haemoglobin, Idiopathic urticaria
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site pain, Injection site pruritus, Injection site reaction, Injection site swelling, Injection site urticaria
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Loss of personal independence in daily activities, Oropharyngeal pain, Pyrexia, Quality of life decreased, Red blood cell sedimentation rate
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Rheumatoid factor, Urticaria
Clinical narrative: Post-vaccine, I experienced what was typically expected of the shingles vaccine, chills, low-grade fever, fatigue and sore throat. But, I also experienced a raised, burning and itching welt at the injection site that grew to the size of my palm over the course of 7-10 days.  Then, during a routine indoor cycle exercise activity on June 14, 2023 , my body was overcome with acute hives within 15 minutes of my workout.  I took a benadryl and called my doctor.  As time progressed, the hives continued with exercise, cold application to the skin, and heat (solar), still present as of this report on 3/29/2024. I was ultimately diagnosed with idiopathic urticaria. I was asked to report this. Please note, I had previ I had previously received five (5) work mandated COVID-19 injections (Pfizer), starting as soon as they were available and spaced appropriately, but the final COVID-19 vaccine was in November 2022. I had no reaction post-COVID-19 vaccine. This spacing of COVID-19 vaccines represents 6 months between a COVID-19 injection and the Zoster (Shingrex) vaccine. The hives have affected my quality of life, and can be highly concerning if I cannot self-mitigate my environment, or get to safety quickly when they flare up. I was prescribed and now carry an Epi pen, and I take daily antihistamines to keep the hives at bay so long as I can control my environment. Despite daily antihistimines, simple things like shopping in a cold grocery store will aggravate the hives and quickly, and though I dress to keep my skin from cold exposure, I cannot cover every part of my body (face). I have found on several occasions that I needed to abort my grocery shopping trip and go to safety.  Once I am back in my controlled environment, the hives will subside completely disappearing within 45 minutes to 1-hour. I am very fearful that I may find myself in a situation that I cannot control my environment. There are many things I can no longer enjoy doing.  My allergist is pointing to the Shingrex vaccine as the culprit to the ongoing idiopathic urticaria, but is not ruling out that the COVID-19 vaccine may also be a cause, if not having compounded the arousal of histamines in body and then added Shingrex, and the outcome is the excessive release of histamines under cold/hot conditions.  As this is now nine (9) months living with trying to gauge when by body will react in environments I cannot control and would not be able retreat quickly could become life threatening. This illness post-Shingrex vaccine has caused a lot of anxiety and worry, and elevates a fear that I could be put in situations that I cannot self-mitigate/control. I currently work at home, but that may not always be the case, and this would expose me to elements that will be out of my control. I have a lot of anxiety over that and always needing to consider or to decline activities for which could put my life in jeopardy.
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19
Clinical narrative: hospitalized with covid; fully vaccinated with 2 boosters
Age: 11.0
Sex: F
Vaccine: TDAP
Symptoms: Abdominal pain upper, Nausea, Streptococcus test negative, Vomiting
Clinical narrative: Symptoms: Nausea, vomiting, severe stomach pain x 7 days (symptoms started within 5 days of receiving vaccine) , no fever, no other signs of viral illness, no other family members, classmates etc. sick, no household members proceeded to get sick following her symptoms
Age: 25.0
Sex: F
Vaccine: RSV
Symptoms: Bell's palsy, C-reactive protein increased, Exposure during pregnancy, Facial paralysis, Hypoaesthesia
Clinical narrative: Pt is a G2P0 at 32w3d when received vaccine. Pt developed left sided facial numbness and drooping that evening and worsening the next few days. Seen in the office two days later and sent to hospital for further evaluation given her hx of IUFD in previous pregnancy. Was diagnosed with Bell's Palsy after imaging, labs, and consult to neurology.
Age: 25.0
Sex: F
Vaccine: RSV
Symptoms: Magnetic resonance imaging normal, Red blood cell sedimentation rate increased
Clinical narrative: Pt is a G2P0 at 32w3d when received vaccine. Pt developed left sided facial numbness and drooping that evening and worsening the next few days. Seen in the office two days later and sent to hospital for further evaluation given her hx of IUFD in previous pregnancy. Was diagnosed with Bell's Palsy after imaging, labs, and consult to neurology.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Nausea, Pyrexia, Vertigo
Clinical narrative: Patient experienced fever starting from 3/28/2024 evening after getting second Shingrix vaccine. Patient's fever got better 3/29/2024 morning per patient. Patient also informed slight nausea feeling and vertigo per patient.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Acne, Blister, Herpes zoster, Pain, Rash erythematous
Clinical narrative: She got her vaccine, had a red rash under her arm pit after 2 days and then it blew into full blown pimples and spread to her chest, back, armpits and has to wear her shorts inside out so that the seam does not rub on it.  She is wearing long sleeve shirts.  She says it looks a mess like she has a road rash.  Under the arm is the most sensitive area as it always moist.  She went to her doctor and he told her that she had shingles, and that she should have shown up when she had a rash and thought that she has shaved too close and it was from there.  She has big blisters from it as well.  He gave her Valacyclovir and she does not know if it's helping.  She is waiting for the blisters to heal up and go away.  Some on her backs have not gone away, the ones under her arm have not and the ones on her chest went away or scabbed over.  She went to the hospital 5 days ago for pain medicine as the pain was intense.  She was given some pain medicine, oxycodone which has helped.  She is resting better since she has gotten that medicine.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site infection, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Initial injection was very painful compared to previous doses and others with me at time of vaccination. Infection. Swelling and redness around injection site lasting longer than 48 hours. Swollen area is hot to the touch. Extremely painful to have touched, sharp pain like repeated injections with needles.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Initial injection was very painful compared to previous doses and others with me at time of vaccination. Infection. Swelling and redness around injection site lasting longer than 48 hours. Swollen area is hot to the touch. Extremely painful to have touched, sharp pain like repeated injections with needles.
Age: 71.0
Sex: F
Vaccine: COVID19-2, FLU4
Symptoms: Unevaluable event
Clinical narrative: pt did not receive vaccines. vaccines incorrectly documented and reported to DOH.
Age: 76.0
Sex: F
Vaccine: UNK
Symptoms: Erythema, Immunisation reaction, Injection site rash, Rash
Clinical narrative: pt developed covid arm (rash, redness around injection site that extended to cover most of her arm)
Age: 74.0
Sex: F
Vaccine: COVID19-2
Symptoms: Erythema, Pain, Pruritus
Clinical narrative: redness, itching, soreness
Age: 0.5
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered
Clinical narrative: Act HIB expired on 3/25/24.